AppMarketSpy › Finance › BioPharma Edge
★ 5.00average rating
1ratings
+1new ratings, last 7 days
—not in top charts now
Ratings breakdown
| ★★★★★ | 100% | |
| ★★★★ | 0% | |
| ★★★ | 0% | |
| ★★ | 0% | |
| ★ | 0% |
🔒 Rating history19 days of daily rating and rating countGet Pro access
App info
- Developer
- BIOVIEW CAPITAL LLC
- Category
- Finance, Education
- Released
- Sep 20, 2026
- Version
- 1.2 (Sep 20, 2026)
- Price
- Free
- Size
- 30.2 MB
- Requires
- iOS 15.1
- Age rating
- 18+
- Languages
- English
In-app purchases
noneCurrent prices, App Store US.
About BioPharma Edge
BioPharma Edge is a curated biotech stock research platform built specifically for self-directed investors who want to navigate one of the market's most volatile, and rewarding sectors with greater clarity and confidence. Rather than reacting to daily market moves, BioPharma Edge follows the clinical, regulatory, and commercial catalysts that shape company outcomes — trial readouts, FDA decisions, and the key milestones ahead of them. Every company we cover is tracked through a consistent research framework; from the moment a catalyst is identified to the moment the thesis is settled. Key Features • Pipeline Follow curated, high-impact biotech stocks through a disciplined research framework. Every company record includes a structured Research Snapshot, Upcoming Catalyst, Opportunity Snapshot, and Outcome Snapshot — plus a full Research Brief covering the science, the competitive…
🔒 Developer intelligencelegal entity, account ID and every app from this sellerGet Pro access